Bill Snyder Archive — Page 2 of 121

Portrait of Annet Kirabo, DVM, MSc, PhD, smiling with her arms crossed while wearing a mauve blazer in an office.
September 30, 2026

Annet Kirabo to receive American Heart Association’s 2026 Joseph A. Vita Award

The award recognizes investigations that have “significantly advanced the fields of cardiovascular biology or cardiovascular health within the past five years.”

September 28, 2026

California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing

The human monoclonal antibodies were isolated from two individuals who had been infected by measles. Further development and clinical testing could lead to the first monoclonal antibody therapy against the highly infectious respiratory virus.

Kevin Byram, MD, wearing glasses, a gray suit, white shirt, and striped tie, standing in a covered building walkway.
September 24, 2026

Kevin Byram named Medical Director of the Vanderbilt Specialty Pharmacy

Accredited as a Rare Disease Pharmacy Center of Excellence, VSP manages specialty medications and offers high-touch pharmacy services for patients with complex and often chronic, rare conditions.

Vanderbilt Health building with a glass facade and rooftop mechanical equipment, photographed against a tree-covered neighborhood.
September 22, 2026

Vanderbilt Health to lead nationwide initiative to improve outcomes for critically ill patients

Funded via ARPA-H, CIRCLE will combine advances in diagnostics and AI to speed development of next-generation interventions that identify and respond to harmful immunoinflammatory states before life-threatening complications occur.

(iStock)
September 11, 2026

Protein clues in the blood may help children avoid diseases later in life

Study identifies early signs of cardiovascular-kidney-metabolic disease in children that potentially can be reversed with a new class of weight loss drugs used widely by adults.

Study design compared a) a single session of transcranial magnetic stimulation to b) an accelerated, multi-session protocol. Each group of participants received pre- and post-session neuroimaging and cognitive assessments.
September 10, 2026

Noninvasive brain stimulation may help reduce cognitive deficits in schizophrenia

The procedure involves a magnetic coil placed on the scalp that generates magnetic pulses that pass through the skull and, by inducing small electrical currents, modulates neural activity in targeted areas of the brain.